Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joel Trugman, MD
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
75 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Achieve Clinical Research
Birmingham, Alabama, United States
- Radiant Research, Inc.
Chandler, Arizona, United States
- the Research Center of Southern California, Llc
Carlsbad, California, United States
- Neuro-Pain Medical Center, Inc
Fresno, California, United States
- Irvine Center for Clinical Research
Irvine, California, United States
- Downtown la Research Center, Inc.
Los Angeles, California, United States
- Excell Research
Oceanside, California, United States
- Artemis Institute for Clinical Research
San Marcos, California, United States
- Diablo Clinical Research Inc
Walnut Creek, California, United States
- Advanced Neurosciences Research
Fort Collins, Colorado, United States
- Hartford Headache Center
East Hartford, Connecticut, United States
- Associated Neurologists of Southern Connecticut, P. C.
Fairfield, Connecticut, United States
- Chase Medical Research, Llc
Waterbury, Connecticut, United States
- the George Washington University
Washington D.C., District of Columbia, United States
- Clinical Research South Florida
Coral Gables, Florida, United States
- Infinity Clinical Research
Hollywood, Florida, United States
- Clinical Neuroscience Solutions Inc
Jacksonville, Florida, United States
- Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
- Meridien Research
Maitland, Florida, United States
- Suncoast Research
Miami, Florida, United States
- Renstar Medical Research
Ocala, Florida, United States
- Clinical Neuroscience Solutions
Orlando, Florida, United States
- Palm Beach Neurological Center / Advanced Research Consultants, Inc.
Palm Beach Gardens, Florida, United States
- Suncoast Neuroscience Associates, Inc.
St. Petersburg, Florida, United States
- Infinity Clinical Research Llc
Sunrise, Florida, United States
- Meridien Research
Tampa, Florida, United States
- Neurology Research Institute Palm Beach
West Palm Beach, Florida, United States
- Institute for Advanced Medical Research
Alpharetta, Georgia, United States
- Atlanta Center for Medical Research
Atlanta, Georgia, United States
- Radiant Research
Atlanta, Georgia, United States
- Iresearch Atlanta, Llc
Decatur, Georgia, United States
- Pediatric and Adolescent Neurodevelopmental Associates (panda) Neurology
Sandy Springs, Georgia, United States
- Clinical Research Atlanta
Stockbridge, Georgia, United States
- Northwest Clinical Trials, Inc.
Boise, Idaho, United States
- Healthcare Research Network Ii, Llc
Blue Island, Illinois, United States
- Rowe Neurology Institute
Lenexa, Kansas, United States
- Boston Clinical Trials Inc
Boston, Massachusetts, United States
- Northeast Medical Research Associates, Inc.
North Dartmouth, Massachusetts, United States
- Medvadis Research Corporation
Watertown, Massachusetts, United States
- New England Regional Headache Center
Worcester, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Sept 2016
- Primary completion
- 2 Apr 2018
- Completion
- 23 Apr 2018
- Last update posted
- 6 Dec 2018
- Registered enrollment
- 834
- Registry id
- NCT02848326
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.